Boyu Capital
Linqi Xue is a seasoned professional in the healthcare investment sector, currently serving as Vice President at Boyu Capital since November 2020, specializing in biotech, medtech, life science tools, and bio-processing. Prior to this role, Linqi Xue was an Associate at EQT Group from January 2019 to November 2020, where the focus was on private equity investments across healthcare, consumer, TMT, and industrial sectors. Earlier experience includes a position as Senior Associate Consultant at L.E.K. Consulting from January 2016 to January 2019, concentrating on strategy consulting in life sciences, consumer markets, and industrials. Linqi Xue holds a Bachelor of Laws (LLB) in International Relations and Affairs from Fudan University, along with a brief educational tenure at The London School of Economics and Political Science in 2013.
This person is not in any offices
Boyu Capital
Boyu Capital is a China-focused investment firm. Their mission is to deliver long-term risk-adjusted returns for the Fund’s investors through a systematic and tailor-made investment approach. They provide growth and transformational capital for fast-growing businesses in Greater China, as well as participating in the restructuring of state-owned enterprises.